Anne Altmeyer

CIK: 0001947086

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jun 10, 2026
Sale(S)
Direct
2.4K shares at avg. $7.91$19K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
May 19, 2026
Award(A)
Direct
3.8K shares-
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 20, 2025
Exercise(M)
Direct
1.1K shares at avg. $4.80$5K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Oct 20, 2025
Sale(S)
Direct
1.1K shares at avg. $20.50$22K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
May 30, 2025
Sale(S)
Direct
1.4K shares at avg. $7.25$10K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
May 30, 2025
Award(A)
Direct
4.8K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	2,412	$7.91	$19,088	Direct
May 19, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	3,800	-	$0	Direct
Oct 20, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Exercise(M)	1,060	$4.80	$5,088	Direct
Oct 20, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	1,060	$20.50	$21,730	Direct
May 30, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	1,392	$7.25	$10,096	Direct
May 30, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	4,800	-	-	Direct

1-6 of 6 transactions

About Altmeyer Anne

Altmeyer Anne (SEC CIK 0001947086) files insider reports with the SEC as Director of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Signal8 holds 4 ownership filings by Altmeyer Anne, all Form 4s, filed between Jun 2, 2025 and Jun 11, 2026. Those filings report 6 transactions, from May 30, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Altmeyer Anne's filings is in NORWOOD, MA.

Recent filings by Altmeyer Anne

Jun 10, 2026: Open-market sale of CRBP shares (Form 4, code S).
May 19, 2026: Grant or award of CRBP shares (Form 4, code A).
Oct 20, 2025: Option exercise of CRBP shares (Form 4, code M).
Oct 20, 2025: Open-market sale of CRBP shares (Form 4, code S).
May 30, 2025: Open-market sale of CRBP shares (Form 4, code S).

Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Cormorant Asset Management, LP, Officer
Ben Yong, Director
Nicacio Leonardo Viana, Chief Medical Officer
Saxena Nishant C, Chief Business Officer
Cohen Yuval, Chief Executive Officer
Moran Sean F., Chief Financial Officer

How to read Form 4 transaction codes